CME Group Inc
NASDAQ:CME
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
193.43
244.8381
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
CME Group Inc
Wall Street
Price Targets
CME Price Targets Summary
CME Group Inc
According to Wall Street analysts, the average 1-year price target for
CME
is 241.47 USD
with a low forecast of 182.81 USD and a high forecast of 288.75 USD.
CME Last Price Targets
CME Group Inc
The latest public price target was made on Oct 24, 2024 by
Owen Lau
from
Oppenheimer
,
who expects
CME
stock to
rise by 8%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Owen Lau
Oppenheimer
|
258
USD
Upside 8% |
1 month ago
Oct 24, 2024
|
CME Group (CME) PT Raised to $258 at Oppenheimer
StreetInsider
|
Benjamin Budish
Barclays
|
231
USD
Downside 3% |
1 month ago
Oct 24, 2024
|
CME Group price target raised to $231 from $219 at Barclays
TheFly
|
Christopher Allen
Citigroup
|
250
USD
Upside 5% |
2 months ago
Oct 3, 2024
|
CME Group price target raised to $250 from $240 at Citi
TheFly
|
Ashish Sabadra
RBC Capital
|
235
USD
Downside 1% |
2 months ago
Sep 26, 2024
|
CME Group initiated with a Sector Perform at RBC Capital
TheFly
|
Craig Siegenthaler
Bank of America Securities
|
177
USD
Downside 26% |
3 months ago
Sep 3, 2024
|
CME Group downgraded to Underperform from Neutral at BofA
TheFly
|
Brian Bedell
Deutsche Bank
|
193
USD
Downside 19% |
4 months ago
Jul 25, 2024
|
CME Group price target lowered to $193 from $195 at Deutsche Bank
TheFly
|
|
Benjamin Budish
Barclays
|
209
USD
Downside 12% |
4 months ago
Jul 25, 2024
|
CME Group price target raised to $209 from $208 at Barclays
TheFly
|
Patrick Moley
Piper Sandler
|
225
USD
Downside 6% |
4 months ago
Jul 25, 2024
|
CME Group (CME) PT Lowered to $225 at Piper Sandler
StreetInsider
|
Alex Kromm
UBS
|
250
USD
Upside 5% |
6 months ago
Jun 5, 2024
|
UBS Reiterates Buy Rating on CME Group (CME)
StreetInsider
|
|
Benjamin Budish
Barclays
|
228
USD
Downside 4% |
7 months ago
Apr 25, 2024
|
CME Group price target raised to $228 from $226 at Barclays
TheFly
|
Andrew Bond
Rosenblatt Securities
|
187
USD
Downside 22% |
7 months ago
Apr 25, 2024
|
CME Group (CME) PT Raised to $187 at Rosenblatt
StreetInsider
|
|
Brian Bedell
Deutsche Bank
|
210
USD
Downside 12% |
8 months ago
Apr 5, 2024
|
Deutsche Bank Downgrades CME Group (CME) to Hold
StreetInsider
|
Unknown Analyst
Credit Suisse
|
198
USD
Downside 17% |
1 year ago
Feb 7, 2023
|
Credit Suisse Maintains Outperform on CME Group, Raises Price Target to $198
Benzinga
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CME's stock price target?
Price Target
241.47
USD
According to Wall Street analysts, the average 1-year price target for
CME
is 241.47 USD
with a low forecast of 182.81 USD and a high forecast of 288.75 USD.
What is CME Group Inc's Revenue forecast?
Projected CAGR
-11%
For the last 8 years the
compound annual growth rate for
CME Group Inc's revenue is
16%.
The projected
CAGR
for the next 4 years is
-11%.
What is CME Group Inc's Operating Income forecast?
Projected CAGR
-14%
For the last 8 years the
compound annual growth rate for
CME Group Inc's operating income is
20%.
The projected
CAGR
for the next 4 years is
-14%.
What is CME Group Inc's Net Income forecast?
Projected CAGR
7%
For the last 8 years the
compound annual growth rate for
CME Group Inc's net income is
12%.
The projected
CAGR
for the next 4 years is
7%.
You don't have any saved screeners yet
